STOCK TITAN

Intuitive Surgical (ISRG) Stock News, Apr-Oct 2020

ISRG NASDAQ

Intuitive Surgical reports developments in robotic-assisted minimally invasive care, centered on its da Vinci surgical systems, da Vinci 5, da Vinci SP, and Ion Endoluminal System. Company news commonly covers procedure volume, system placements, installed-base growth, instruments and accessories revenue, operating lease placements, and share repurchase activity.

Updates also include FDA clearances that expand indications for Intuitive platforms, such as cardiac procedures for da Vinci 5 and additional procedures for da Vinci SP. News about the company also reflects completed commercial expansion in Europe, including direct operations for da Vinci and Ion distribution in Southern European markets.

Rhea-AI Summary

Intuitive Surgical (Nasdaq: ISRG) has launched Intuitive Ventures, a $100 million fund aimed at investing in minimally invasive care innovations. This fund will focus on early-stage companies in digital tools, precision diagnostics, and therapeutic technologies. Julian Nikolchev, President of Intuitive Ventures, emphasizes the goal to enhance the continuum of care. With a leadership team experienced in healthcare investment, Intuitive Ventures aims to leverage industry expertise to drive positive healthcare outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
-
Rhea-AI Summary

Intuitive (Nasdaq: ISRG) reported Q3 financial results for 2020, revealing a revenue decline of 4% year-over-year to $1,078 million. The company shipped 195 da Vinci Surgical Systems, a decrease of 29% compared to 2019. Despite challenges from COVID-19, da Vinci procedures increased by 7%, and the installed base grew to 5,865 systems, up 8% from last year. Net income fell to $314 million, or $2.60 per diluted share, down from $397 million, or $3.33 per diluted share in Q3 2019. The company also launched a $100 million fund for healthcare innovations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
-
Rhea-AI Summary

Intuitive (Nasdaq: ISRG) reported Q2 2020 revenue of $852 million, down 22% from $1,099 million in Q2 2019, heavily impacted by the COVID-19 pandemic. Worldwide da Vinci procedures declined 19%, and the shipment of da Vinci Surgical Systems fell 35% to 178 units. The installed base of systems grew 9% to 5,764. GAAP net income was $68 million ($0.57/share), down from $318 million ($2.67/share) last year. The company ended the quarter with $6.1 billion in cash and equivalents. Despite challenges, Intuitive launched an 'Extended Use Program' for instruments to improve economic efficacy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.52%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
covid-19
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.64%
Tags
management

FAQ

What is the current stock price of Intuitive Surgical (ISRG)?

Intuitive Surgical (ISRG) last closed at $420.95.

What is the market cap of Intuitive Surgical (ISRG)?

The market cap of Intuitive Surgical (ISRG) is approximately $145.9B.